Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Step-wise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.

Bæk KT, Thøgersen L, Mogenssen RG, Mellergaard M, Thomsen LE, Petersen A, Skov S, Cameron DR, Peleg AY, Frees D.

Antimicrob Agents Chemother. 2015 Aug 31. pii: AAC.01303-15. [Epub ahead of print]

PMID:
26324273
2.

Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit.

Abbott IJ, Jenney AW, Spelman DW, Pilcher DV, Sidjabat HE, Richardson LJ, Paterson DL, Peleg AY.

Pathology. 2015 Aug 22. [Epub ahead of print]

PMID:
26308128
3.

Differentiation of Acinetobacter Genomic Species 13BJ/14TU from Acinetobacter haemolyticus using MALDI - TOF MS.

Toh BE, Zowawi HM, Krizova L, Paterson DL, Kamolvit W, Peleg AY, Sidjabat H, Nemec A, Pflüger V, Huber CA.

J Clin Microbiol. 2015 Jul 29. pii: JCM.03468-14. [Epub ahead of print]

PMID:
26224844
4.

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.

Walsh CC, McIntosh MP, Peleg AY, Kirkpatrick CM, Bergen PJ.

J Antimicrob Chemother. 2015 Jul 24. pii: dkv221. [Epub ahead of print]

PMID:
26209311
5.

Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens.

Rack JG, Morra R, Barkauskaite E, Kraehenbuehl R, Ariza A, Qu Y, Ortmayer M, Leidecker O, Cameron DR, Matic I, Peleg AY, Leys D, Traven A, Ahel I.

Mol Cell. 2015 Jul 16;59(2):309-20. doi: 10.1016/j.molcel.2015.06.013. Epub 2015 Jul 9.

6.

Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210.

Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY.

Genome Announc. 2015 Jun 11;3(3). pii: e00568-15. doi: 10.1128/genomeA.00568-15.

7.

Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis.

Dexter C, Murray GL, Paulsen IT, Peleg AY.

Expert Rev Anti Infect Ther. 2015 May;13(5):567-73. doi: 10.1586/14787210.2015.1025055.

PMID:
25850806
8.

Impact of daptomycin resistance on Staphylococcus aureus virulence.

Cameron DR, Mortin LI, Rubio A, Mylonakis E, Moellering RC Jr, Eliopoulos GM, Peleg AY.

Virulence. 2015;6(2):127-31. doi: 10.1080/21505594.2015.1011532.

PMID:
25830650
9.

Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies.

Abbott IJ, Peleg AY.

Semin Respir Crit Care Med. 2015 Feb;36(1):99-110. doi: 10.1055/s-0034-1396929. Epub 2015 Feb 2.

PMID:
25643274
10.

Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Doi Y, Murray GL, Peleg AY.

Semin Respir Crit Care Med. 2015 Feb;36(1):85-98. doi: 10.1055/s-0034-1398388. Epub 2015 Feb 2.

PMID:
25643273
11.

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.

Trials. 2015 Jan 27;16:24. doi: 10.1186/s13063-014-0541-9.

12.

Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period.

Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY.

Transpl Infect Dis. 2014 Dec;16(6):887-96. doi: 10.1111/tid.12298. Epub 2014 Oct 9.

PMID:
25298044
13.

Antimicrobial stewardship in residential aged care facilities: need and readiness assessment.

Lim CJ, Kwong M, Stuart RL, Buising KL, Friedman ND, Bennett N, Cheng AC, Peleg AY, Marshall C, Kong DC.

BMC Infect Dis. 2014 Jul 23;14:410. doi: 10.1186/1471-2334-14-410.

14.

Antibiotic prescribing practice in residential aged care facilities--health care providers' perspectives.

Lim CJ, Kwong MW, Stuart RL, Buising KL, Friedman ND, Bennett NJ, Cheng AC, Peleg AY, Marshall C, Kong DC.

Med J Aust. 2014 Jul 21;201(2):98-102. Erratum in: Med J Aust. 2014 Nov 17;201(10):574. Peleg, Anton [corrected to Peleg, Anton Y].

PMID:
25045989
15.

Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study.

Lim CJ, Cheng AC, Kennon J, Spelman D, Hale D, Melican G, Sidjabat HE, Paterson DL, Kong DC, Peleg AY.

J Antimicrob Chemother. 2014 Jul;69(7):1972-80. doi: 10.1093/jac/dku077. Epub 2014 Apr 7.

16.

Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study.

Lim CJ, Cheng AC, Kong DC, Peleg AY.

BMC Infect Dis. 2014 Mar 4;14:126. doi: 10.1186/1471-2334-14-126.

17.

A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway.

Cerqueira GM, Kostoulias X, Khoo C, Aibinu I, Qu Y, Traven A, Peleg AY.

J Infect Dis. 2014 Jul 1;210(1):46-55. Epub 2014 Jan 14.

18.

OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital.

Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, Sandalli C.

Clin Microbiol Infect. 2014 May;20(5):410-5. doi: 10.1111/1469-0691.12338. Epub 2013 Aug 19.

19.

Population genetics and the evolution of virulence in Staphylococcus aureus.

Chua KY, Howden BP, Jiang JH, Stinear T, Peleg AY.

Infect Genet Evol. 2014 Jan;21:554-62. doi: 10.1016/j.meegid.2013.04.026. Epub 2013 Apr 27. Review.

PMID:
23628638
20.

The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.

Howden BP, Peleg AY, Stinear TP.

Infect Genet Evol. 2014 Jan;21:575-82. doi: 10.1016/j.meegid.2013.03.047. Epub 2013 Apr 6. Review.

PMID:
23567819
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk